RP-1664 |
RP-1664 : Inhibitor of PLK4
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PLK4 |
|
Inhibitor
up to 100 nM
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
RP-11664 showed high selectivity across the kinome with significant binding observed with only six o ...
Selectivity Assessment Description:
Kinase binding selectivity was performed at ActivX Biosciences using the Kinativ kinase profiling pl ...
Potency Cellular
In Vitro
PLK4
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acs.jmedchem.5c00529
In Vivo Validations
Mouse
Dose: 1 mg/Kg IV, 5 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
11 mL/min/Kg IV
Bioavailability:
113% PO
DOI Reference: 10.1021/acs.jmedchem.5c00529
Rat
Dose: 1.0 mg/Kg IV, 2.5 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
5.9 mL/min/Kg IV
Bioavailability:
28% PO
DOI Reference: 10.1021/acs.jmedchem.5c00529
Dog
Dose: 0.5 mg/Kg IV, 1.15 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
30 mL/min/Kg IV
Bioavailability:
98% PO
DOI Reference: 10.1021/acs.jmedchem.5c00529
Monkey (Cynomolgus)
Dose: o.5 mg/Kg IV, 1.25 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
14 mL/min/Kg IV
Bioavailability:
96% PO
DOI Reference: 10.1021/acs.jmedchem.5c00529
Chemical Information
| Molecular Formula | C23H24F2N8O2S |
| SMILEs | Cc1cc(Nc2nc(N(C)c3c(F)cc(S(C)(=O)=O)cc3F)nc(-c3cn(C)cn3)c2C2CC2)n[nH]1 |
| InChI | InChI=1S/C23H24F2N8O2S/c1-12-7-18(31-30-12)27-22-19(13-5-6-13)20(17-10-32(2)11-26-17)28-23(29-22)33(3)21-15(24)8-14(9-16(21)25)36(4,34)35/h7-11,13H,5-6H2,1-4H3,(H2,27,28,29,30,31) |
| Molecular weight | 514.17 Da |
| AlogP | 3.9792200000000024 |
| HBond acceptors | 10 |
| HBond donors | 2 |
| Atoms | 60 |